United states military cancer institute clinical trials group (USMCI GI-01) randomized controlled trial comparing targeted nodal assessment and ultrastaging with standard pathological evaluation for colon cancer

Annals of Surgery

Volumn 256, Issue 3, 2012, Pages 412-427

  Nissan, Aviram ^a,b   Protic, Mladjan ^b,c,d   Bilchik, Anton J ^a,e,f   Howard, Robin S ^g   Peoples, George E ^h   Stojadinovic, Alexander ^g,i  

^a RABIN MEDICAL CENTER   (Israel)

^b United States Military Cancer Institute   (United States)

^c Clinical Center of Vojvodina   (Serbia)

^d UNIVERSITY OF NOVI SAD   (Serbia)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f California Oncology Research Institute   (United States)

^g WALTER REED ARMY MEDICAL CENTER   (United States)

^h BROOKE ARMY MEDICAL CENTER   (United States)

ⁱ UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

cancer recurrence; colon cancer; disease free survival; lymph node; lymph node yield; quality indicator; sentinel node; staging; targeted nodal assessment

Indexed keywords

ACCURACY; ADULT; AGED; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TARGETED NODAL ASSESSMENT AND ULTRASTAGING; UNITED STATES;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLONIC NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY;

EID: 84865470694     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31826571c8     Document Type: Conference Paper

References (42)

1. Labianca R, Merelli B. Screening and diagnosis for colorectal cancer: present and future. Tumori. 2010;96:889-901.
2. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116:544-573.
3. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
4. Dukes CE. Cancer of the rectum: an analysis of 1000 cases. J Pathol. 1940;50:527-539.
5. Dukes CE. The surgical pathology of rectal cancer. J Clin Pathol. 1949;2: 95-98.
6. 2010 Staging System for CRC. Ann Surg Oncol. 2011;18:1513-1517.
7. Baxter NN, Virnig DJ, Rothenberger DA, et al. Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst. 2005;97:219-225. (Pubitemid 40277372)
8. Cohen Am, Kelsen D, Saltz L, et al. Adjuvant therapy for colorectal cancer. Curr Probl Cancer. 1998;22:5-65.
9. Rahbari NN, Bork U, Motschall E, et al. Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysis. J Clin Oncol. 2012;30:60-70.
10. Stojadinovic A, Nissan A, Protic M, et al. Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study GI-01. Ann Surg. 2007;245:846-857. (Pubitemid 46809284)
11. Schulz KF, Atman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152:1-7. http://www.consort-statement.org/consort- statement.
12. Stojadinovic A, Allen PJ, Protic M, et al. Colon sentinel lymph node mapping: practical surgical applications. J Am Coll Surg. 2005;201:297-313. (Pubitemid 40994964)
13. Martinez SR, Bilchik AJ. Lymphatic mapping and sentinel node analysis in colon cancer. Clin Colorectal Cancer. 2005;4:320-324. (Pubitemid 40309378)
14. Wood TF, Saha S, Morton DL, et al. Validation of lymphatic mapping in colorectal cancer: in vivo, ex vivo, and laparoscopic techniques. Ann Surg Oncol. 2001;8:150-157. (Pubitemid 32199412)
15. Wood TF, Spirt M, Rangel D, et al. Lymphatic mapping improves staging during laparoscopic colectomy for cancer [published online ahead of print May 2, 2001]. Surg Endosc. 2001;15:715-719. (Pubitemid 32622620)
16. Cox ED, Kellicut D, Adair C, et al. Sentinel lymph node evaluation is technically feasible and may improve staging in colorectal cancer. Curr Surg. 2002;59:301-306.
17. Wood TF, Nora DT, Morton DL, et al. One hundred consecutive cases of sentinel lymph node mapping in early colorectal carcinoma: detection ofmissed micrometastases. J Gastrointest Surg. 2002;6:322-329; discussion 229-230.
18. Bilchik AJ, DiNome M, Saha S, et al. Prospective multicenter trial of staging adequacy in colon cancer: preliminary results. Arch Surg. 2006;141:527-533; discussion 533-534.
19. Bilchik A, Nissan A, Wainberg Z, et al. Surgical quality and nodal ultrastaging is associated with long-term disease-free survival in early colorectal cancer: an analysis of 2 international multicenter prospective trials. Ann Surg. 2010;252:467-474; discussion 474-476.
20. Mescoli C, Albertoni L, Pucciarelli S, et al. Isolated tumor cells in regional lymph nodes as relapse predictors in stage I and II colorectal cancer. J Clin Oncol. 2012;30:965-971.
21. McDonald JR, Renehan AG, O'Dwyer ST, et al. Lymph node harvest in colon and rectal cancer: current considerations.World J Gastrointest Surg. 2012;4:9-19.
22. Hermanek P. [Oncologic surgery/pathologic-anatomic viewpoint]. Langenbecks Archiv Chir Suppl Kongressbd. 1991:277-281. German.
23. Scott KW, Grace RH. Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg. 1989;76:1165-1167. (Pubitemid 19284443)
24. Hermaneck P. [International documentation system for colorectal cancer-reporting pathological findings]. Verh Dtsch Ges Pathol. 1991;75:386-388.
25. Shia J, Wang H, Nash GM, et al. Lymph node staging in colorectal cancer: revisiting the benchmark of at least 12 lymph nodes in R0 resection. J AmColl Surg. 2012;214:348-355.
26. Chen SL, Bilchik AJ. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg. 2006;244:602-610.
27. Chen SL, Steele SR, Eberhardt J, et al. Lymph node ratio as a quality and prognostic indicator in stage III colon cancer. Ann Surg. 2011;253:82-87.
28. Iddings D, Ahmad A, Elashoff D, et al. The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: a meta-analysis. Ann Surg Oncol. 2006;13:1386-1392. (Pubitemid 44749649)
29. Bertagnolli M, Miedema B, Redston M, et al. Sentinel node staging of resectable colon cancer: results of a multicenter study. Ann Surg. 2004;240:624-628; discussion 628-630.
30. RedstonM, Compton CC, Miedema BW, et al. LeukemiaGroup B Trial 80001. Analysis of micrometastatic disease in sentinel lymph nodes from resectable colon cancer: results of Cancer and Leukemia Group B Trial 80001. J Clin Oncol. 2006;24:878-883. (Pubitemid 46638839)
31. Bilchik AJ, Hoon DS, Saha S, et al. Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial. Ann Surg. 2007;246:568-575; discussion 575-577. (Pubitemid 47480600)
32. Ozao-Choy J, Giuliano AE. Prognostic significance of micrometastasis and isolated tumor cells in the sentinel lymph node [published online ahead of print November 3, 2010]. Breast Cancer Res Treat. 2011;127:205-206.
33. Giuliano AE, Hawes D, Ballman KV, et al. Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. JAMA. 2011;306:385-393.
34. Balch CM, Gershenwald JE, Soong SJ, Thompson JF.Update on themelanoma staging system: the importance of sentinel node staging and primary tumor mitotic rate. J Surg Oncol. 2011;104:379-385.
35. Balch CM, Soong SJ, Atkins MB, et al. An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin. 2004;54:131-149; quiz 182-184. (Pubitemid 38812179)
36. Viehl CT, Guller U, Cecini R, et al. Sentinel lymph node procedure leads to upstaging of patients with resectable colon cancer: results of the Swiss prospective, multicenter study sentinel lymph node procedure in colon cancer. Ann Surg Oncol. 2012;19:1959-1965.
37. Soreide K, Nedrebo BS, Soreide JA, et al. Lymph node harvest in colon cancer: influence of microsatellite instability and proximal tumor location. World J Surg. 2009;33:2695-2703.
38. Eveno C, Nemeth J, Soliman H, et al. Association between a high number of isolated lymph nodes in T1 to T4N0M0 colorectal cancer and the microsatellite instability phenotype. Arch Surg. 2010;145:12-17.
39. Short SS, Stojadinovic A, Nissan A, et al. Adjuvant treatment of early colon cancer with micrometastases: results of a national survey. J Surg Oncol. 2012;106:119-122.
40. Bilchik AJ, Saha S,Wiese D, et al. Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial. J Clin Oncol. 2001;19:1128.
41. Dawson K, Wiebusch A, Thirlby RC. Preoperative tattooing and improved lymph node retrieval rates from colectomy specimens in patientswith colorectal cancers. Arch Surg. 2010;145:826-830.
42. Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003;21:2912-2919. (Pubitemid 46621841)